Droperidol is a butyrophenone antipsychotic and antiemetic agent primarily used to manage agitation, nausea, and vomiting in surgical and emergency settings. By blocking dopamine D2 receptors, this medication… Read more

![Chemical structure of 1-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F60373-71-9-1-1-Benzyl-1236-tetrahydropyridin-4-yl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)
![Chemical structure of 1-(Pyridin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F110763-56-9-1-Pyridin-4-yl-13-dihydro-2H-benzodimidazol-2-one.png&w=3840&q=75)

![Chemical structure of 4-Desfluoro-4-[4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)-3,6-dihydropyridin-1(2H)-yl] Droperidol-d4](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1346604-49-6-4-Desfluoro-4-4-2-Oxo-23-dihydro-1H-benzimidazol-1-yl-36-dihydropyridin-12H-yl-Droperidol-d4.png&w=3840&q=75)














Droperidol is a butyrophenone antipsychotic and antiemetic agent primarily used to manage agitation, nausea, and vomiting in surgical and emergency settings. By blocking dopamine D2 receptors, this medication induces a state of neuroleptanalgesia, often in combination with opioid analgesics, to keep patients calm yet cooperative during medical procedures. Laboratories utilize high-quality reference standards of droperidol, including its pharmacopeial and non-pharmacopeial impurities, to support rigorous impurity profiling and method validation. The category also encompasses critical tools for quantitative analysis, such as stable isotope labelled compounds and identified metabolites like N-nitroso derivatives. These standards are essential for quality control protocols, ensuring that pharmaceutical manufacturers can accurately detect, quantify, and characterize droperidol-related substances throughout the product lifecycle and regulatory compliance testing.